πŸ‡ΊπŸ‡Έ FDA
Patent

US 11970483

Heterocyclic compound

granted A61KA61K45/06A61P

Quick answer

US patent 11970483 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K45/06, A61P, A61P1/10